Post-genomics nanotechnology is gaining momentum: Nanoproteomics and applications in life sciences

OMICS A Journal of Integrative Biology

Volumn 18, Issue 2, 2014, Pages 111-131

  Kobeissy, Firas H ^a,e   Gulbakan, Basri ^b,c   Alawieh, Ali ^d   Karam, Pierre ^e   Zhang, Zhiqun ^a   Guingab Cagmat, Joy D ^f   Mondello, Stefania ^g   Tan, Weihong ^a,b,h   Anagli, John ^f   Wang, Kevin ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b University of Florida   (United States)

^c ETH ZURICH   (Switzerland)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^f BANYAN BIOMARKERS INC   (United States)

^g UNIVERSITY OF MESSINA   (Italy)

^h H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CA 125 ANTIGEN; CARBON; GOLD NANOPARTICLE; MAGNETIC NANOPARTICLE; METAL OXIDE; NANOMATERIAL; NANOPARTICLE; PLATELET DERIVED GROWTH FACTOR; POROUS POLYMER; PROSTATE SPECIFIC ANTIGEN; QUANTUM DOT; SILICON;

AUTOIMMUNE DISEASE; BIOMEDICINE; BRAIN INJURY; CAPILLARY ELECTROPHORESIS; DRUG DELIVERY SYSTEM; EXPERIMENTAL STROKE; GENOMICS; HUMAN; IMMUNOASSAY ANALYZER; IMMUNOSENSOR; LENS; METABOLOMICS; NANOBIOTECHNOLOGY; NANOPROTEOMICS; NANOTECHNOLOGY; PHOSPHONANOPROTEOMICS; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW;

AUTOIMMUNE DISEASES; BIOLOGICAL SCIENCE DISCIPLINES; BIOSENSING TECHNIQUES; COMMUNICABLE DISEASES; HUMANS; IMMUNOASSAY; INDIVIDUALIZED MEDICINE; MOLECULAR TARGETED THERAPY; NANOSTRUCTURES; NANOTECHNOLOGY; NEOPLASMS; PROTEOMICS;

EID: 84893391720     PISSN: 15362310     EISSN: 15578100     Source Type: Journal    
DOI: 10.1089/omi.2013.0074     Document Type: Review

References (244)

1. Abul-Husn NS, and Devi LA. (2006). Neuroproteomics of the synapse and drug addiction. J Pharmacol Exp Ther 318,461-468.
2. Aebersold R, and Mann M. (2003). Mass spectrometry-based proteomics. Nature 422,198-207.
3. Ahmed FE. (2009). Sample preparation and fractionation for proteome analysis and cancer biomarker discovery by mass spectrometry. J Sep Sci 32, 771-798.
4. Alaouie AM, and Sofou S. (2008). Liposomes with triggered content release for cancer therapy. J Biomed Nanotechnol 4, 234-244.
5. Altelaar AF, Munoz J, and Heck AJ. (2013). Next-generation proteomics: Towards an integrative view of proteome dynamics. Nat Rev Genet 14, 35-48.
6. Anderson NL, and Anderson NG. (2002). The human plasma proteome: History, character, and diagnostic prospects. Mol Cell Proteomics 1, 845-867.
7. Ansari AA, Kaushik A, Solanki PR, and Malhotra BD. (2010). Nanostructured zinc oxide platform for mycotoxin detection. Bioelectrochemistry 77, 75-81.
8. Archakov A. (2007). Introducing Nanoproteomics, a new section in proteomics. Proteomics 7, 4409-4412.
9. Bagos PG, Liakopoulos TD, Spyropoulos IC, and Hamodrakas SJ. (2004). A Hidden Markov Model method, capable of predicting and discriminating beta-barrel outer membrane proteins. BMC Bioinformatics 5, 29.
10. Bamrungsap S, Shukoor MI, Chen T, Sefah K, and Tan W. (2011). Detection of lysozyme magnetic relaxation switches based on aptamer-functionalized superparamagnetic nanoparticles. Anal Chem 83, 7795-7799.
11. Becker M, Schindler J, and Nothwang HG. (2006). Neuroproteomics - The tasks lying ahead. Electrophoresis 27, 2819-2829.
12. Becker RC. (2006). Preoteomics, metabolomics and circulating endothelial progenitor cells in acute coronary syndromes. J Thromb Thrombolysis 21, 203-206.
13. Berretta R, and Moscato P. (2010). Cancer biomarker discovery: The entropic hallmark. PLoS One 5, e12262.
14. Bin X, Sargent EH, and Kelley SO. (2010). Nanostructuring of sensors determines the efficiency of biomolecular capture. Anal Chem 82, 5928-5931.
15. Boeneman K, Mei BC, Dennis AM, et al. (2009). Sensing caspase 3 activity with quantum dot-fluorescent protein assemblies. J Am Chem Soc 131, 3828-3829.
16. Bouamrani A, Serda R, and Ferrari M. (2009). Mesoporous silicon nanotechnology for cancer application. Oncologie 11, 143-147.
17. Breus VV, Heyes CD, Tron K, and Nienhaus GU. (2009). Zwitterionic biocompatible quantum dots for wide pH stability and weak nonspecific binding to cells. ACS Nano 3, 2573-2580.
18. Bruchez M, Moronne M, Gin P, Weiss S, and Alivisatos AP. (1998). Semiconductor nanocrystals as fluorescent biological labels. Science 281, 2013-2016.
19. Chan WC, and Nie S. (1998). Quantum dot bioconjugates for ultrasensitive nonisotopic detection. Science 281, 2016-2018.
20. Chen C-T, and Chen Y-C. (2005). Fe3O4/TiO2 core/shell nanoparticles as affinity probes for the analysis of phospho- peptides using TiO2 surface-assisted laser desorption/ionization mass spectrometry. Anal Chem 77, 5912-5919.
21. Chen CT, and Chen YC. (2008). A two-matrix system for MALDI MS analysis of serine phosphorylated peptides concentrated by Fe3O4/Al2O3 magnetic nanoparticles. J Mass Spectrom 43, 538-541.
22. Chen M-L, He Y-J, Chen X-W, and Wang J-H. (2013). Quantumdot- conjugated graphene as a probe for simultaneous cancertargeted fluorescent imaging, tracking and monitoring drug delivery. Bioconjug Chem 24, 387-397.
23. Chen RJ, Choi HC, Bangsaruntip S, et al. (2004). An investigation of the mechanisms of electronic sensing of protein adsorption on carbon nanotube devices. J Am Chem Soc 126, 1563-1568.
24. Chen Z, Tabakman SM, Goodwin AP, et al. (2008). Protein microarrays with carbon nanotubes as multicolor Raman labels. Nat Biotech 26, 1285-1292.
25. Chou PH, Chen SH, Liao HK, et al. (2005). Nanoprobe-based affinity mass spectrometry for selected protein profiling in human plasma. Anal Chem 77, 5990-5997.
26. Choudhary J, and Grant SG. (2004). Proteomics in postgenomic neuroscience: The end of the beginning. Nat Neurosci 7, 440-445.
27. Clement CC, Cannizzo ES, Nastke M-D, et al. (2010). An expanded self-antigen peptidome is carried by the human lymph as compared to the plasma. PloS One 5, e9863.
28. Cochran DA, Evans CA, Blinco D, et al. (2003). Proteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig V(H) genes. Mol Cell Proteomics 2, 1331-1341.
29. Collins FS, Morgan M, and Patrinos A. (2003). The Human Genome Project: Lessons from large-scale biology. Science 300, 286-290.
30. Coon JJ, Ueberheide B, Syka JE, et al. (2005). Protein identification using sequential ion/ion reactions and tandem mass spectrometry. Proc Natl Acad Sci USA 102, 9463-9468.
31. Cottingham K. (2008). HUPOA? 's Human Proteome Project: The next big thing? J Proteome Res 7, 2192.
32. Cox J, and Mann M. (2007). Is proteomics the new genomics? Cell 130, 395-398.
33. Cui Y, Wei Q, Park H, and Lieber CM. (2001). Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 293, 1289-1292.
34. Dahan M, Levi S, Luccardini C, Rostaing P, Riveau B, and Triller A. (2003). Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 302, 442-5.
35. Das J, and Kelley SO. (2011). Protein detection using arrayed microsensor chips: Tuning sensor footprint to achieve ultrasensitive readout of CA-125 in serum and whole blood. Anal Chem 83, 1167-1172.
36. de Gracia Villa M, Jime?nez-Jorquera C, Haro I, et al. (2011). Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis. Biosensors Bioelectron 27, 113-118.
37. De M, Rana S, Akpinar H, et al. (2009). Sensing of proteins in human serum using conjugates of nanoparticles and green fluorescent protein. Nature Chem 1, 461-465.
38. Dean RA, and Overall CM. (2007). Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol Cell Proteomics 6, 611-623.
39. Denslow N, Michel ME, Temple MD, Hsu CY, Saatman K, and Hayes RL. (2003). Application of proteomics technology to the field of neurotrauma. J Neurotrauma 20, 401-407.
40. Dong X, Cheng J, Li J, and Wang Y. (2010). Graphene as a novel matrix for the analysis of small molecules by MALDI-TOF MS. Anal Chem 82, 6208-6214.
41. Drouvalakis KA, Bangsaruntip S, Hueber W, Kozar LG, Utz PJ, and Dai H. (2008). Peptide-coated nanotube-based biosensor for the detection of disease-specific autoantibodies in human serum. Biosens Bioelectron 23, 1413-1421.
42. Dumont D, Noben JP, Raus J, Stinissen P, and Robben J. (2004). Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 4, 2117-2124.
43. Dupre M, Coffinier Y, Boukherroub R, Cantel S, Martinez J, and Enjalbal C. (2012). Laser desorption ionization mass spectrometry of protein tryptic digests on nanostructured silicon plates. J Proteomics 75, 1973-1990.
44. Engholm-Keller K, and Larsen MR. (2013). Technologies and challenges in large-scale phosphoproteomics. Proteomics 13, 910-931.
45. Fan J, Deng X, Gallagher JW, et al. (2012). Monitoring the progression of metastatic breast cancer on nanoporous silica chips. Philos Trans A Math Phys Eng Sci 370, 2433-2447.
46. Fan J, Huang Y, Finoulst I, et al. (2013). Serum peptidomic biomarkers for pulmonary metastatic melanoma identified by means of a nanopore-based assay. Cancer Lett 334, 202-210.
47. Fang G, Gao W, Deng Q, Qian K, Han H, and Wang S. (2012). Highly selective capture of phosphopeptides using a nano titanium dioxide-multiwalled carbon nanotube nanocomposite. Anal Biochem 423, 210-217.
48. Farace F, Massard C, Vimond N, et al. (2011). A direct comparison of CellSearch and ISET for circulating tumour-cell detection in patients with metastatic carcinomas. Br J Cancer 105, 847-853.
49. Ferrari M. (2005). Cancer nanotechnology: Opportunities and challenges. Nat Rev Cancer 5, 161-171.
50. Feuerstein I, Morandell S, Stecher G, et al. (2005). Phosphoproteomic analysis using immobilized metal ion affinity chromatography on the basis of cellulose powder. Proteomics 5, 46-54.
51. Finnskog D, Jaras K, Ressine A, et al. (2006). High-speed biomarker identification utilizing porous silicon nanovial arrays and MALDI-TOF mass spectrometry. Electrophoresis 27, 1093-1103.
52. Freeman WM, Brebner K, Amara SG, Reed MS, Pohl J, and Phillips AG. (2005). Distinct proteomic profiles of amphetamine self-administration transitional states. Pharmacogenomics J 5, 203-214.
53. Gandhi S, and Wood NW. (2012). The human genome project- What it really means and where next. Neurogenetics: A Guide for Clinicians, 1.
54. Geho D, Lahar N, Gurnani P, et al. (2005). Pegylated, steptavidinconjugated quantum dots are effective detection elements for reverse-phase protein microarrays. Bioconjug Chem 16, 559-566.
55. Geho D, Ming-Cheng Cheng M, Killian K, et al. (2006). Fractionation of serum components using nanoporous substrates. Bioconjug Chem 17, 654-661.
56. Georganopoulou DG, Chang L, Nam JM, et al. (2005). Nanoparticle- based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci USA 102, 2273-2276.
57. Giannetto M, Elviri L, Careri M, Mangia A, and Mori G. (2011). A voltammetric immunosensor based on nanobiocomposite materials for the determination of alpha-fetoprotein in serum. Biosens Bioelectron 26, 2232-2236.
58. Gorris HH, and Walt DR. (2010). Analytical chemistry on the femtoliter scale. Angew Chem Int Ed Engl 49, 3880-3895.
59. Gu H, Xu K, Xu C, and Xu B. (2006). Biofunctional magnetic nanoparticles for protein separation and pathogen detection. Chem Commun (Camb) 941-949.
60. Chem Commun (Camb) 941-949. Gulbakan B, Park D, Kang M, et al. (2010). Laser desorption ionization mass spectrometry on silicon nanowell arrays. Anal Chem 82, 7566-7575.
61. Gunnarsson L, Rindzevicius T, Prikulis J, et al. (2005). Confined plasmons in nanofabricated single silver particle pairs: Experimental observations of strong interparticle interactions. J Phys Chem B 109, 1079-1087.
62. Guo Y, Huang L, Baeyens WR, Delanghe JR, He D, and Ouyang J. (2009). Novel application of carbon nanotubes for improving resolution in detecting human serum proteins with native polyacrylamide gel electrophoresis. Nano Lett 9, 1320-1324.
63. Guo Z, Ren J, Wang J, and Wang E. (2011). Single-walled carbon nanotubes based quenching of free FAM-aptamer for selective determination of ochratoxin A. Talanta 85, 2517-2521.
64. Hahm Jong-in MLC. (2004). Direct ultrasensitive electrical detection of DNA and DNA sequence variations using nanowire nanosensors. Nano Lett 4, 51-54.
65. Han D, Zhu Z, Wu C, et al. (2012). A logical molecular circuit for programmable and autonomous regulation of protein activity using DNA aptamer-protein interactions. J Am Chem Soc 134, 20797-20804.
66. Hanaki K-i, Momo A, Oku T, et al. (2003). Semiconductor quantum dot/albumin complex is a long-life and highly photostable endosome marker. Biochem Biophys Res Commun 302, 496-501.
67. He Z, Zhang Q, Wang H, and Li Y. (2011). Continuous highthroughput phosphopeptide enrichment using microfluidic channels modified with aligned ZnO/TiO2 nanorod arrays. Biomed Microdevices 13, 865-875.
68. Hill HD, Millstone JE, Banholzer MJ, and Mirkin CA. (2009). The role radius of curvature plays in thiolated oligonucleotide loading on gold nanoparticles. ACS Nano 3, 418-424.
69. Hill HD, and Mirkin CA. (2006). The bio-barcode assay for the detection of protein and nucleic acid targets using DTTinduced ligand exchange. Nature Protocols 1, 324-336.
70. Hoheisel TN, Schrettl S, Szilluweit R, and Frauenrath H. (2010). Nanostructured carbonaceous materials from molecular precursors. Angew Chem Int Ed Engl 49, 6496-6515.
71. Hood L, and Friend SH. (2011). Predictive, personalized, preventive, participatory (P4) cancer medicine. Nat Rev Clin Oncol 8, 184-7.
72. Hortin GL, and Sviridov D. (2010). The dynamic range problem in the analysis of the plasma proteome. J Proteomics 73, 629-636.
73. Hsu W-Y, Lin W-D, Hwu W-L, Lai C-C, and Tsai F-J. (2010). Screening assay of very long chain fatty acids in human plasma with multiwalled carbon nanotube-based surfaceassisted laser desorption/Ionization mass spectrometry. Anal Chem 82, 6814-6820.
74. Hu Y, Bouamrani A, Tasciotti E, Li L, Liu X, and Ferrari M. (2009). Tailoring of the nanotexture of mesoporous silica films and their functionalized derivatives for selectively harvesting low molecular weight protein. ACS Nano 4, 439-451.
75. Hunnerkopf R, Grassl J, and Thome J. (2007). [Proteomics: biomarker research in psychiatry]. Fortschr Neurol Psychiatr 75, 579-586.
76. Husi H, and Grant SG. (2001). Proteomics of the nervous system. Trends Neurosci 24, 259-266.
77. Ibraheem A, and Campbell RE. (2010). Designs and applications of fluorescent protein-based biosensors. Curr Opin Chem Biol 14, 30-36.
78. Jain P, Baker GL, and Bruening ML. (2009). Applications of polymer brushes in protein analysis and purification. Annu Rev Anal Chem (Palo Alto Calif) 2, 387-408.
79. Jaiswal JK, Mattoussi H, Mauro JM, and Simon SM. (2002). Long-term multiple color imaging of live cells using quantum dot bioconjugates. Nature Biotechnol 21, 47-51.
80. Jane A, Dronov R, Hodges A, and Voelcker NH. (2009). Porous silicon biosensors on the advance. Trends Biotechnol 27, 230-239.
81. Ji SR, Liu C, Zhang B, et al. (2010). Carbon nanotubes in cancer diagnosis and therapy. Biochim Biophys Acta 1806, 29-35.
82. Jimeńez V, de Gracia M, Jimeńez Jorquera C, et al. (2012). Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis. Biosens Bioelectron 27, 113-118.
83. Jin WH, Dai J, Zhou H, Xia QC, Zou HF, and Zeng R. (2004). Phosphoproteome analysis of mouse liver using immobilized metal affinity purification and linear ion trap mass spectrometry. Rapid Commun Mass Spectrom 18, 2169-2176.
84. Johnson SA, and Hunter T. (2004). Phosphoproteomics finds its timing. Nat Biotechnol 22, 1093-1094.
85. Kang M, Trofin L, Mota MO, and Martin CR. (2005). Protein capture in silica nanotube membrane 3-D microwell arrays. Anal Chem 77, 6243-6249.
86. Karas M, Gluckmann M, and Schafer J. (2000). Ionization in matrix-assisted laser desorption/ionization: Singly charged molecular ions are the lucky survivors. J Mass Spectrom 35, 1-12.
87. Kaushik A, Solanki PR, Ansari AA, Ahmad S, and Malhotra BD. (2009a). A nanostructured cerium oxide film-based immunosensor for mycotoxin detection. Nanotechnology 20, 055105.
88. Kaushik A, Solanki PR, Sood K, Ahmad S, and Malhotra BD. (2009b). Fumed silica nanoparticles-chitosan nanobiocomposite for ochratoxin-A detection. Electrochem Commun 11, 1919-1923.
89. Khoury GA, Baliban RC, and Floudas CA. (2011). Proteomewide post-translational modification statistics: Frequency analysis and curation of the swiss-prot database. Sci Rep 1.
90. Kim EY, Stanton J, Korber BT, et al. (2008). Detection of HIV-1 p24 Gag in plasma by a nanoparticle-based bio-barcodeamplification method. Nanomedicine (Lond) 3, 293-303.
91. Kim S, Lim YT, Soltesz EG, et al. (2004a). Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22, 93-97.
92. Kim SI, Voshol H, van Oostrum J, Hastings TG, Cascio M, and Glucksman MJ. (2004b). Neuroproteomics: Expression profiling of the brain's proteomes in health and disease. Neurochem Res 29, 1317-1331.
93. Kim SY, Yu J, Son SJ, and Min J. (2010). Signal enhancement in a protein chip array using a 3-D nanosurface. 11th International Scanning Probe Microscopy Conference 110, 659-665.
94. Kim TH, Lee S, and Chen X. (2013). Nanotheranostics for personalized medicine. Expert Rev Mol Diagn 13, 257-269.
95. Kneipp K, Kneipp H, Itzkan I, Dasari RR, and Feld MS. (1999). Ultrasensitive chemical analysis by Raman spectroscopy. Chem Rev 99, 2957-2976.
96. Kneipp K, Kneipp H, Kartha VB, et al. (1998). Detection and identification of a single DNA base molecule using surfaceenhanced Raman scattering (SERS). Phys Rev E 57, R6281.
97. Kneipp K, Wang Y, Kneipp H, et al. (1997). Single molecule detection using surface-enhanced Raman scattering (SERS). Phys Rev Lett 78, 1667.
98. Kobeissy FH, Sadasivan S, Liu J, Gold MS, and Wang KK. (2008a). Psychiatric research: Psychoproteomics, degradomics and systems biology. Expert Rev Proteomics 5, 293-314.
99. Kobeissy FH, Sadasivan S, Oli MW, et al. (2008b). Neuroproteomics and systems biology-based discovery of protein bio- markers for traumatic brain injury and clinical validation. Proteomics Clin Appl 2, 1467-1483.
100. Kobeissy FH, Warren M, Wang KKW, and Gold MS. (2008c). Using psychoproteomics to identify protein pathways relevant to methamphetamine neurotoxicity. Biological Psychiatry 63, 91s-91s.
101. Kobeissy FH, Warren MW, Ottens AK, et al. (2008d). Psychoproteomic analysis of rat cortex following acute methamphetamine exposure. J Proteome Res 7, 1971-1983.
102. Kweon HK, and Hakansson K. (2008). Metal oxide-based enrichment combined with gas-phase ion-electron reactions for improved mass spectrometric characterization of protein phosphorylation. J Proteome Res 7, 749-755.
103. LaFratta CN, and Walt DR. (2008). Very high density sensing arrays. Chem Rev 108, 614-637.
104. Lai X. (2013). Reproducible method to enrich membrane proteins with high purity and high yield for an LC-MS/MS approach in quantitative membrane proteomics. Electrophoresis 34, 809-817.
105. Lamond AI, Uhlen M, Horning S, et al. (2012). Advancing cell biology through proteomics in space and time (PROSPECTS). Mol Cell Proteomics 11, O112 017731.
106. Lander ES, Linton LM, Birren B, et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921.
107. Larsen MR, Cordwell SJ, and Roepstorff P. (2002). Graphite powder as an alternative or supplement to reversed-phase material for desalting and concentration of peptide mixtures prior to matrix-assisted laser desorption/ionization-mass spectrometry. Proteomics 2, 1277-1287.
108. Larsen MR, Graham ME, Robinson PJ, and Roepstorff P. (2004). Improved detection of hydrophilic phosphopeptides using graphite powder microcolumns and mass spectrometry. Mol Cell Proteomics 3, 456-465.
109. Larsen MR, Thingholm TE, Jensen ON, Roepstorff P, and J?rgensen TJ. (2005). Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol Cell Proteomics 4, 873-886.
110. Larson DR, Zipfel WR, Williams RM, et al. (2003). Water-soluble quantum dots for multiphoton fluorescence imaging in vivo. Science 300, 1434-1436.
111. Lee A, Yang HJ, Lim ES, Kim J, and Kim Y. (2008). Enrichment of phosphopeptides using bare magnetic particles. Rapid Commun Mass Spectrom 22, 2561-2564.
112. Lee KB, Park S, and Mirkin CA. (2004). Multicomponent magnetic nanorods for biomolecular separations. Angew Chem Int Ed Engl 43, 3048-3050.
113. Lee SJ, Morrill AR, and Moskovits M. (2006). Hot spots in silver nanowire bundles for surface-enhanced Raman spectroscopy. J Am Chem Soc 128, 2200-2201.
114. Leitner A. (2010). Phosphopeptide enrichment using metal oxide affinity chromatography. TrAC Trends Anal Chem 29, 177-185.
115. Lemoine J, Fortin T, Salvador A, Jaffuel A, Charrier J-P, and Choquet-Kastylevsky G. (2012). The current status of clinical proteomics and the use of MRM and MRM3 for biomarker validation. Expert Rev Mol Diagnos 12, 333-342.
116. Leutwyler WK, Bu? rgi SL, and Burgl H. (1996). Semiconductor clusters, nanocrystals, and quantum dots. Science 271, 933.
117. Levene MJ, Dombeck DA, Kasischke KA, Molloy RP, and Webb WW. (2004). In vivo multiphoton microscopy of deep brain tissue. J Neurophysiol 91, 1908-1912.
118. Li M, Fernando G, van Waasbergen LG, Cheng X, Ratner BD, and Kinsel GR. (2007a). Thermoresponsive MALDI probe surfaces as a tool for protein on-probe purification. Anal Chem 79, 6840-6844.
119. Li M, Timmons RB, and Kinsel GR. (2005a). Radio frequency plasma polymer coatings for affinity capture MALDI mass spectrometry. Anal Chem 77, 350-353.
120. Li X, Wilm M, and Franz T. (2005b). Silicone/graphite coating for on-target desalting and improved peptide mapping performance of matrix-assisted laser desorption/ionization-mass spectrometry targets in proteomic experiments. Proteomics 5, 1460-1471.
121. Li Y, Leng T, Lin H, et al. (2007b). Preparation of Fe3O4@ZrO2 core shell microspheres as affinity probes for selective enrichment and direct determination of phosphopeptides using matrix-assisted laser desorption ionization mass spectrometry. J Proteome Res 6, 4498-4510.
122. Li Y, Liu Y, Tang J, et al. (2007c). Fe3O4@Al2O3 magnetic coreshell microspheres for rapid and highly specific capture of phosphopeptides with mass spectrometry analysis. J Chromatogr A 1172, 57-71.
123. Li Y, Xu X, Qi D, Deng C, Yang P, and Zhang X. (2008). Novel Fe3O4@TiO2 core shell microspheres for selective enrichment of rhosphopeptides in rhosphoproteome analysis. J Proteome Res 7, 2526-2538.
124. Liang SS, Makamba H, Huang SY, and Chen SH. (2006). Nanotitanium dioxide composites for the enrichment of phosphopeptides. J Chromatogr A 1116, 38-45.
125. Lin B, Li T, Zhao Y, Huang FK, Guo L, and Feng YQ. (2008). Preparation of a TiO2 nanoparticle-deposited capillary column by liquid phase deposition and its application in phosphopeptide analysis. J Chromatogr A 1192, 95-102.
126. Lin H-Y, Chen W-Y, and Chen Y-C. (2009). Iron oxide/niobium oxide core shell magnetic nanoparticle-based phosphopeptide enrichment from biological samples for MALDI MS analysis. J Biomed Nanotechnol 5, 215-223.
127. Lin Y, Pan Y, Shi Y, Huang X, Jia N, and Jiang J-y. (2012). Delivery of large molecules via poly (butyl cyanoacrylate) nanoparticles into the injured rat brain. Nanotechnology 23, 165101.
128. Liu J, Lau SK, Varma VA, Kairdolf BA, and Nie S. (2010). Multiplexed detection and characterization of rare tumor cells in Hodgkin's lymphoma with multicolor quantum dots. Anal Chem 82, 6237-6243.
129. Liu W, Howarth M, Greytak AB, et al. (2008). Compact biocompatible quantum dots functionalized for cellular imaging. J Am Chem Soc 130, 1274-1284.
130. Liu Y, Solomon M, and Achilefu S. (2013). Perspectives and potential applications of nanomedicine in breast and prostate cancer. Med Res Rev 33, 3-32.
131. Longo C, Patanarut A, George T, et al. (2009). Core-shell hydrogel particles harvest, concentrate and preserve labile low abundance biomarkers. PLoS One 4, e4763.
132. Lu J, Wang M, Li Y, and Deng C. (2012). Facile synthesis of TiO2/graphene composites for selective enrichment of phosphopeptides. Nanoscale 4, 1577-1580.
133. Lu Z, Duan J, He L, Hu Y, and Yin Y. (2010). Mesoporous TiO2 nanocrystal clusters for selective enrichment of phosphopeptides. Anal Chem 82, 7249-7258.
134. Luchini A, Geho DH, Bishop B, et al. (2008). Smart hydrogel particles: Biomarker harvesting: One-step affinity purification, size exclusion, and protection against degradation. Nano Lett 8, 350-361.
135. Luong-Van E, Rodriguez I, Low HY, et al. (2013). Review: Microand nanostructured surface engineering for biomedical applications. J Materials Res 28, 165-174.
136. Mahmoud KA, Hrapovic S, and Luong JH. (2008). Picomolar detection of protease using peptide/single walled carbon nanotube/gold nanoparticle-modified electrode. ACS Nano 2, 1051-1057.
137. Malhotra R, Patel V, Chikkaveeraiah BV, et al. (2012). Ultrasensitive detection of cancer biomarkers in the clinic by use of a nanostructured microfluidic array. Anal Chem 84, 6249-6255.
138. Mann M, and Jensen ON. (2003). Proteomic analysis of posttranslational modifications. Nat Biotechnol 21, 255-261.
139. Mann M, Ong S-E, Gr?nborg M, Steen H, Jensen ON, and Pandey A. (2002). Analysis of protein phosphorylation using mass spectrometry: Deciphering the phosphoproteome. Trends Biotechnol 20, 261-268.
140. Mattigod SV, Fryxell GE, Alford K, et al. (2005). Functionalized TiO2 nanoparticles for use for in situ anion immobilization. Environ Sci Technol 39, 7306-7310.
141. Medintz IL, Clapp AR, Mattoussi H, Goldman ER, Fisher B, and Mauro JM. (2003). Self-assembled nanoscale biosensors based on quantum dot FRET donors. Nat Mater 2, 630-638.
142. Missler M, and Sudhof TC. (1998). Neurexins: Three genes and 1001 products. Trends Genet 14, 20-26.
143. Mitchell P. (2010). Proteomics retrenches. Nat Biotechnol 28, 665-670.
144. Morales-Narva?ez E, Monto?n H, Fomicheva A, and Merkoc?i A. (2012). Signal enhancement in antibody microarrays using quantum dots nanocrystals: Application to potential Alzheimer's disease biomarker screening. Anal Chem 84, 6821-6827.
145. Morrison RS, Kinoshita Y, Johnson MD, et al. (2002). Proteomic analysis in the neurosciences. Mol Cell Proteomics 1, 553-560.
146. Murray C, Norris D, and Bawendi MG. (1993). Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites. J Am Chem Soc 115, 8706-8715.
147. Najam-ul-Haq M, Jabeen F, Hussain D, et al. (2012). Versatile nanocomposites in phospho-proteomics: A review. Anal Chim Acta 747, 7-18.
148. Najam-ul-Haq M, Rainer M, Huck CW, Hausberger P, Kraushaar H, and Bonn GnK. (2008). Nanostructured diamond-like carbon on digital versatile sisc as a matrix-free target for laser desorption/ionization mass spectrometry. Anal Chem 80, 7467-7472.
149. Nam JM, Thaxton CS, and Mirkin CA. (2003). Nanoparticlebased bio-bar codes for the ultrasensitive detection of proteins. Science 301, 1884-1886.
150. Nelson CA, Szczech JR, Xu Q, Lawrence MJ, Jin S, and Ge Y. (2009). Mesoporous zirconium oxide nanomaterials effectively enrich phosphopeptides for mass spectrometry-based phosphoproteomics. Chem Commun (Camb) 43, 6607-6609.
151. Neubert H, Gale J, and Muirhead D. (2010). Online high-flow peptide immunoaffinity enrichment and nanoflow LC-MS/ MS: Assay development for total salivary pepsin/pepsinogen. Clin Chem 56, 1413-1423.
152. Neves MM, Gonza?lez-García MB, Nouws H, and Costa-García A. (2012). Celiac disease detection using a transglutaminase electrochemical immunosensor fabricated on nanohybrid screen-printed carbon electrodes. Biosensors Bioelectron 31, 95-100.
153. Nie S, and Emory SR. (1997). Probing single molecules and single nanoparticles by surface-enhanced Raman scattering. Science 275, 1102-1106.
154. Nie S, Xing Y, Kim GJ, and Simons JW. (2007). Nanotechnology applications in cancer. Annu Rev Biomed Eng 9, 257-288.
155. Northen TR, Yanes O, Northen MT, et al. (2007). Clathrate nanostructures for mass spectrometry. Nature 449, 1033-1036.
156. Ocsoy I, Gulbakan B, Shukoor MI, et al. (2013). Aptamer conjugated multifunctional nanoflowers as a platform for targeting, capture and detection in laser desorption ionization mass spectrometry. ACS nano 7 (1), pp. 417-427.
157. Oh BK, Nam JM, Lee SW, and Mirkin CA. (2006). A fluorophorebased bio-barcode amplification assay for proteins. Small 2,103-8.
158. Okuno J, Maehashi K, Kerman K, Takamura Y, Matsumoto K, and Tamiya E. (2007). Label-free immunosensor for prostate-specific antigen based on single-walled carbon nanotube array-modified microelectrodes. Biosens Bioelectron 22, 2377-2381.
159. Olsen JV, Vermeulen M, Santamaria A, et al. (2010). Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci Signal 3, ra3.
160. Omenn GS. (2012). The HUPO Human Proteome Project (HPP), a Global Health Research Collaboration. Central Asian J Global Health 1.
161. Oppermann FS, Gnad F, Olsen JV, et al. (2009). Large-scale proteomics analysis of the human kinome. Mol Cell Proteomics 8, 1751-1764.
162. Ortiz M, Fragoso A, and O'Sullivan CK. (2011). Detection of antigliadin autoantibodies in celiac patient samples using a cyclodextrin-based supramolecular biosensor. Anal Chem 83, 2931-2938.
163. Ottens AK. (2009). The methodology of neuroproteomics. Methods Mol Biol 566, 1-21.
164. Ottens AK, Kobeissy FH, Golden EC, et al. (2006). Neuroproteomics in neurotrauma. Mass Spectrom Rev 25, 380-408.
165. Pagba CV, Lane SM, Cho H, and Wachsmann-Hogiu S. (2010). Direct detection of aptamer-thrombin binding via surface-enhanced Raman spectroscopy. J Biomed Opt 15, 047006.
166. Panini NV, Messina GA, Salinas E, Fernandez H, and Raba J. (2008). Integrated microfluidic systems with an immunosensor modified with carbon nanotubes for detection of prostate specific antigen (PSA) in human serum samples. Biosens Bioelectron 23, 1145-1151.
167. Parker AR, and Townley HE. (2007). Biomimetics of photonic nanostructures. Nat Nanotechnol 2, 347-353.
168. Pathak S, Davidson MC, and Silva GA. (2007). Characterization of the functional binding properties of antibody conjugated quantum dots. Nano Lett 7, 1839-1845.
169. Patolsky F, Zheng G, Hayden O, Lakadamyali M, Zhuang X, and Lieber CM. (2004). Electrical detection of single viruses. Proc Natl Acad Sci USA 101, 14017-14022.
170. Petricoin EF, Zoon KC, Kohn EC, Barrett JC, and Liotta LA. (2002). Clinical proteomics: Translating benchside promise into bedside reality. Nature Rev Drug Disc 1, 683-695.
171. Petros RA, and DeSimone JM. (2010). Strategies in the design of nanoparticles for therapeutic applications. Nat Rev Drug Discov 9, 615-627.
172. Pinaud F, Michalet X, Bentolila LA, et al. (2006). Advances in fluorescence imaging with quantum dot bio-probes. Biomaterials 27, 1679-1687.
173. Podstawka E, Ozaki Y, and Proniewicz LM. (2004). Adsorption of SS containing proteins on a colloidal silver surface studied by surface- enhanced Raman spectroscopy. Appl Spectrosc 58, 1147-1156.
174. Ranzoni A, Sabatte G, van Ijzendoorn LJ, and Prins MW. (2012). One-step homogeneous magnetic nanoparticle immunoassay for biomarker detection directly in blood plasma. ACS Nano 6, 3134-3141.
175. Ray S, Reddy PJ, Choudhary S, Raghu D, and Srivastava S. (2011). Emerging nanoproteomics approaches for disease biomarker detection: A current perspective. J Proteomics 74, 2660-2681.
176. Ressine A, Corin I, Jaras K, et al. (2007). Porous silicon surfaces: A candidate substrate for reverse protein arrays in cancer biomarker detection. Electrophoresis 28, 4407-4415.
177. Rifai N, Gillette MA, and Carr SA. (2006). Protein biomarker discovery and validation: The long and uncertain path to clinical utility. Nat Biotechnol 24, 971-983.
178. Rissin DM, Kan CW, Campbell TG, et al. (2010). Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nature Biotechnol 28, 595-599.
179. Rissin DM, and Walt DR. (2006). Digital concentration readout of single enzyme molecules using femtoliter arrays and Poisson statistics. Nano Lett 6, 520-523.
180. Rosenthal SJ, Tomlinson I, Adkins EM, et al. (2002). Targeting cell surface receptors with ligand-conjugated nanocrystals. J Am Chem Soc 124, 4586-4594.
181. Rosi NL, Thaxton CS, and Mirkin CA. (2004). Control of nanoparticle assembly by using DNA-modified diatom templates. Angew Chem Int Ed Engl 43, 5500-5503.
182. Rusling JF, Munge B, Sardesai NP, Malhotra R, and Chikkaveeraiah BV. (2013). Nanoscience-based electrochemical sensors and arrays for detection of cancer biomarker proteins. In: Nanobioelectrochemistry, Springer. pp 1-26.
183. Sailor MJ. (2007). Color me sensitive: Amplification and discrimination in photonic silicon nanostructures. ACS Nano 1, 248-252.
184. Sander J. Tans, Alwin R. M. Verschueren, and Dekker C. (1998). Room-temperature transistor based on a single carbon nanotube. Nature 393, 49-52.
185. Shaffer C. (2011). Mass spec makes its way into the clinic: Outof- the-box solutions ease transition by lowering costs and improving user friendliness. Genetic Engineer Biotechnol News 31, 16-18.
186. Shukoor MI, Natalio F, Tahir MN, et al. (2008). Multifunctional polymer-derivatized [gamma]-Fe2O3 nanocrystals as a methodology for the biomagnetic separation of recombinant Histagged proteins. J Magnet Magnetic Materials 320, 2339-2344.
187. Smith JC, and Figeys D. (2006). Proteomics technology in systems biology. Mol Biosyst 2, 364-370.
188. Stern E, Klemic JF, Routenberg DA, et al. (2007). Label-free immunodetection with CMOS-compatible semiconducting nanowires. Nature 445, 519-522.
189. Stoevesandt O, and Taussig MJ. (2012). European and international collaboration in affinity proteomics. N Biotechnol 29, 511-514.
190. Sukhanova A, Devy J, Venteo L, et al. (2004). Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells. Anal Biochem 324, 60-67.
191. Sunner J, Dratz E, and Chen YC. (1995). Graphite surfaceassisted laser desorption/ionization time-of-flight mass spectrometry of peptides and proteins from liquid solutions. Anal Chem 67, 4335-4342.
192. Swaney DL, Wenger CD, Thomson JA, and Coon JJ. (2009). Human embryonic stem cell phosphoproteome revealed by electron transfer dissociation tandem mass spectrometry. Proc Natl Acad Sci USA 106, 995-1000.
193. Tabakman SM, Lau L, Robinson JT, et al. (2011). Plasmonic substrates for multiplexed protein microarrays with femtomolar sensitivity and broad dynamic range. Nat Commun 2, 466.
194. Tan J, Zhao WJ, Yu JK, Ma S, Sailor MJ, and Wu JM. (2012). Capture, enrichment, and mass spectrometric detection of low-molecular-weight biomarkers with nanoporous silicon microparticles. Adv Healthc Mater 1, 742-750.
195. Tang D, and Ren J. (2008). In situ amplified electrochemical immunoassay for carcinoembryonic antigen using horseradish peroxidase-encapsulated nanogold hollow microspheres as labels. Anal Chem 80, 8064-8070.
196. Tang D, Yuan R, Chai Y, Dai J, Zhong X, and Liu Y. (2004). A novel immunosensor based on immobilization of hepatitis B surface antibody on platinum electrode modified colloidal gold and polyvinyl butyral as matrices via electrochemical impedance spectroscopy. Bioelectrochemistry 65, 15-22.
197. Tang D, Yuan R, Chai Y, et al. (2005). New amperometric and potentiometric immunosensors based on gold nanoparticles/tris (2, 2'-bipyridyl) cobalt (III) multilayer films for hepatitis B surface antigen determinations. Biosensors Bioelectron 21, 539-548.
198. Tang LA, Wang J, and Loh KP. (2010). Graphene-based SELDI probe with ultrahigh extraction and sensitivity for DNA oligomer. J Am Chem Soc 132, 10976-10977.
199. Tang S, and Hewlett I. (2010). Nanoparticle-based immunoassays for sensitive and early detection of HIV-1 capsid (p24) antigen. J Infect Dis 201 Suppl 1, S59-64.
200. Tang S, Moayeri M, Chen Z, et al. (2009). Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles. Clin Vaccine Immunol 16, 408-413.
201. Tang S, Zhao J, Storhoff JJ, et al. (2007). Nanoparticle-based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. J Acquir Immune Defic Syndr 46, 231-237.
202. Tao WA, Wollscheid B, O'Brien R, et al. (2005b). Quantitative phosphoproteome analysis using a dendrimer conjugation chemistry and tandem mass spectrometry. Nat Methods 2, 591-598.
203. Tawfick S, De Volder M, Copic D, et al. (2012). Engineering of micro- and nanostructured surfaces with anisotropic geometries and properties. Adv Mater 24,1628-1674.
204. Thaxton CS, Elghanian R, Thomas AD, et al. (2009). Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy. Proc Natl Acad Sci USA 106, 18437-18442.
205. Thingholm TE, J?rgensen TJ, Jensen ON, and Larsen MR. (2006). Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nature Prot 1, 1929-1935.
206. Torta F, Fusi M, Casari CS, Bottani CE, and Bachi A. (2009). Titanium dioxide coated MALDI plate for on target analysis of phosphopeptides. J Proteome Res 8, 1932-1942.
207. Vo-Dinh T. (2005). Protein nanotechnology: The new frontier in biosciences. Methods Mol Biol 300, 1-13.
208. Voura EB, Jaiswal JK, Mattoussi H, and Simon SM. (2004). Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med 10, 993-998.
209. Vuckovic D, Dagley LF, Purcell AW, and Emili A. (2013). Membrane proteomics by high performance liquid chromatographytandem mass spectrometry: Analytical approaches and challenges. Proteomics 13, 404-423.
210. Wang G, Wang Y, Chen L, and Choo J. (2010). Nanomaterialassisted aptamers for optical sensing. Biosens Bioelectron 25, 1859-1868.
211. Wang H, Levin CS, and Halas NJ. (2005a). Nanosphere arrays with controlled sub-10-nm gaps as surface-enhanced Raman spectroscopy substrates. J Am Chem Soc 127, 14992-14993.
212. Wang KK, Ottens A, Haskins W, et al. (2004). Proteomics studies of traumatic brain injury. Int Rev Neurobiol 61, 215-240.
213. Wang KK, Ottens AK, Liu MC, et al. (2005b). Proteomic identification of biomarkers of traumatic brain injury. Expert Rev Proteomics 2, 603-614.
214. Webster TJ. (2006). Nanomedicine: What's in a definition? Int J Nanomed 1, 115-116.
215. Wei J, Buriak JM, and Siuzdak G. (1999). Desorption-ionization mass spectrometry on porous silicon. Nature 399, 243-246.
216. Williams K, Wu T, Colangelo C, and Nairn AC. (2004). Recent advances in neuroproteomics and potential application to studies of drug addiction. Neuropharmacology 47 Suppl 1, 148-166.
217. Wisniewski JR, Zougman A, Nagaraj N, and Mann M. (2009). Universal sample preparation method for proteome analysis. Nat Methods 6, 359-362.
218. Witze ES, Old WM, Resing KA, and Ahn NG. (2007). Mapping protein post-translational modifications with mass spectrometry. Nat Methods 4, 798-806.
219. Woodsmith J, Kamburov A, and Stelzl U. (2013). Dual coordination of post translational modifications in human protein networks. PLoS Comput Biol 9, e1002933.
220. Wu Q, and Maniatis T. (1999). A striking organization of a large family of human neural cadherin-like cell adhesion genes. Cell 97, 779-790.
221. Wu X, Liu H, Liu J, et al. (2003). Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 21, 41-46.
222. Xu C, Xu K, Gu H, et al. (2004a). Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. J Am Chem Soc 126, 9938-9939.
223. Xu C, Xu K, Gu H, et al. (2004b). Nitrilotriacetic acid-modified magnetic nanoparticles as a general agent to bind histidinetagged proteins. J Am Chem Soc 126, 3392-3393.
224. Xu S, Li Y, Zou H, Qiu J, Guo Z, and Guo B. (2003). Carbon nanotubes as assisted matrix for laser desorption/ionization time-of-flight mass spectrometry. Anal Chem 75, 6191-6195.
225. Yanes O, Woo HK, Northen TR, et al. (2009). Nanostructure initiator mass spectrometry: Tissue imaging and direct biofluid analysis. Anal Chem 81, 2969-2675.
226. Yang C, Wang Y, Marty J-L, and Yang X. (2011). Aptamer-based colorimetric biosensing of Ochratoxin A using unmodified gold nanoparticles indicator. Biosensors Bioelectron 26, 2724-2727.
227. Yang M, Kostov Y, and Rasooly A. (2008). Carbon nanotubes based optical immunodetection of Staphylococcal Enterotoxin B (SEB) in food. Int J Food Microbiol 127, 78-83.
228. Yasun E, Gulbakan B, Ocsoy I, et al. (2012). Enrichment and detection of rare proteins with aptamer-conjugated gold nanorods. Anal Chem 84, 6008-6015.
229. Yates JR, 3rd. (2013). The revolution and evolution of shotgun proteomics for large-scale proteome analysis. J Am Chem Soc 135, 1629-1640.
230. Yau Y. (2013). Current status and advances in quantitative proteomic mass spectrometry. Intl J Proteomics 2013, 180605.
231. Yin P, Wang Y, Li Y, Deng C, Zhang X, and Yang P. (2012). Preparation of sandwich-structured graphene/mesoporous silica composites with C8-modified pore wall for highly efficient selective enrichment of endogenous peptides for mass spectrometry analysis. Proteomics 12, 2784-2791.
232. Yoon J-Y. (2013). Immunosensors. In: Introduction to Biosensors, Springer. pp 199-223.
233. You C-C, Miranda OR, Gider B, et al. (2007). Detection and identification of proteins using nanoparticle-fluorescent polymer 'chemical nose'sensors. Nature Nanotechnol 2, 318-323.
234. Yun X, Maximov VD, Yu J, Zhu H, Vertegel AA, and Kindy MS. (2013). Nanoparticles for targeted delivery of antioxidant enzymes to the brain after cerebral ischemia and reperfusion injury. J Cereb Blood Flow Metab 33, 583-592.
235. Zeng YY, Chen HJ, Shiau KJ, Hung SU, Wang YS, and Wu CC. (2012). Efficient enrichment of phosphopeptides by magnetic TiO(2)-coated carbon-encapsulated iron nanoparticles. Proteomics 12, 380-390.
236. Zhang CY, Yeh HC, Kuroki MT, and Wang TH. (2005). Singlequantum- dot-based DNA nanosensor. Nat Mater 4, 826-831.
237. Zhang J, Li S, and Li X. (2009). Polymeric nano-assemblies as emerging delivery carriers for therapeutic applications: A review of recent patents. Recent Patents Nanotechnol 3, 225-231.
238. Zhang Y, Fonslow BR, Shan B, Baek MC, and Yates JR, 3rd. (2013). Protein analysis by shotgun/bottom-up proteomics. Chem Rev 113, 2343-2394.
239. Zhao LX, Liu AC, Yu SW, et al. (2013). The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury. Biol Pharm Bull 36, 1263-1270.
240. Zhao Y, and Jensen ON. (2009). Modification-specific proteomics: Strategies for characterization of post-translational modifications using enrichment techniques. Proteomics 9, 4632-4641.
241. Zheng G, Patolsky F, Cui Y, Wang WU, and Lieber CM. (2005). Multiplexed electrical detection of cancer markers with nanowire sensor arrays. Nat Biotechnol 23, 1294-1301.
242. Zhong Z, Wu W, Wang D, et al. (2010). Nanogold-enwrapped graphene nanocomposites as trace labels for sensitivity enhancement of electrochemical immunosensors in clinical immunoassays: Carcinoembryonic antigen as a model. Biosensors Bioelectron 25, 2379-2383.
243. Zhou H, Tian R, Ye M, et al. (2007). Highly specific enrichment of phosphopeptides by zirconium dioxide nanoparticles for phosphoproteome analysis. Electrophoresis 28, 2201-2215.
244. Zubarev RA. (2013). The challenge of the proteome dynamic range and its implications for in-depth proteomics. Proteomics 13, 723-726.